The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Related Posts
Democrats highlight a casualty of the spending fight: funding to combat pediatric cancer.
Democrats highlight a casualty of the spending fight: funding to combat pediatric cancer.
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
‘Imminent Threat’ Found at Boar’s Head Plant 2 Years Before Listeria Outbreak
U.S. inspectors listed serious problems in 2022 that could have resulted in strict measures like a pause in production. But…